CHICAGO, June 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today provided an update on the growing momentum of C-Sept™ PRO, a proprietary antiseptic solution from its high-margin infection-control portfolio, across leading public and private hospital groups in Greece. C-Sept PRO has generated average monthly sales exceeding $93,000 over the past six months, accelerating to more than $108,000 per month over the past three months.